Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wim Janssens

Showing results (1-10 of 241) with videos related to

Pageof 25
Sort By:
Respiratory Physiology & Neurobiology|December 22, 2015
Quantifying the shape of the maximal expiratory flow-volume curve to address flow limitationMarko Topalovic, Wim Janssens
The Lancet. Infectious Diseases|September 17, 2021
Remdesivir, on the road to DisCoVeRyIwein Gyselinck, Wim Janssens
The Lancet. Respiratory Medicine|December 11, 2013
Chronic obstructive pulmonary disease and comorbiditiesMarc Decramer, Wim Janssens
The European Respiratory Journal|March 7, 2020
The CICERO (Collaboration In COPD ExaceRbatiOns) Clinical Research CollaborationWim Janssens, Mona Bafadhel, , et al.
JBMR Plus|December 24, 2021
Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and KlothoGhislaine Gayan-Ramirez, Wim Janssens
European Respiratory Review : an Official Journal of the European Respiratory Society|March 22, 2023
Nonpharmacological interventions in COPDWim Janssens, Geert M Verleden
Accident; Analysis and Prevention|August 8, 2006
The effect of norms, attitudes and habits on speeding behavior: scale development and model building and estimationPatrick De Pelsmacker, Wim Janssens
Lancet (London, England)|February 9, 2012
Chronic obstructive pulmonary diseaseMarc Decramer, Wim Janssens, Marc Miravitlles
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2015
Innate immune modulation in chronic obstructive pulmonary disease: moving closer toward vitamin D therapyNele Heulens, Hannelie Korf, Wim Janssens
American Journal of Respiratory and Critical Care Medicine|January 17, 2013
Severe vitamin D deficiency: a biomarker of exacerbation risk?Nele Heulens, Marc Decramer, Wim Janssens
Pageof 25

Showing results (1-10 of 241) with videos related to

Sort By:
Pageof 25
Respiratory Physiology & Neurobiology|December 22, 2015
Quantifying the shape of the maximal expiratory flow-volume curve to address flow limitationMarko Topalovic, Wim Janssens
The Lancet. Infectious Diseases|September 17, 2021
Remdesivir, on the road to DisCoVeRyIwein Gyselinck, Wim Janssens
The Lancet. Respiratory Medicine|December 11, 2013
Chronic obstructive pulmonary disease and comorbiditiesMarc Decramer, Wim Janssens
The European Respiratory Journal|March 7, 2020
The CICERO (Collaboration In COPD ExaceRbatiOns) Clinical Research CollaborationWim Janssens, Mona Bafadhel, , et al.
JBMR Plus|December 24, 2021
Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and KlothoGhislaine Gayan-Ramirez, Wim Janssens
European Respiratory Review : an Official Journal of the European Respiratory Society|March 22, 2023
Nonpharmacological interventions in COPDWim Janssens, Geert M Verleden
Accident; Analysis and Prevention|August 8, 2006
The effect of norms, attitudes and habits on speeding behavior: scale development and model building and estimationPatrick De Pelsmacker, Wim Janssens
Lancet (London, England)|February 9, 2012
Chronic obstructive pulmonary diseaseMarc Decramer, Wim Janssens, Marc Miravitlles
The Journal of Pharmacology and Experimental Therapeutics|March 11, 2015
Innate immune modulation in chronic obstructive pulmonary disease: moving closer toward vitamin D therapyNele Heulens, Hannelie Korf, Wim Janssens
American Journal of Respiratory and Critical Care Medicine|January 17, 2013
Severe vitamin D deficiency: a biomarker of exacerbation risk?Nele Heulens, Marc Decramer, Wim Janssens
Pageof 25